Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Encephalitis, Japanese”

85 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 85 results

Large-scale testing (Phase 3)Study completedNCT01092507
What this trial is testing

Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers

Who this might be right for
EncephalitisJapanese Encephalitis
Sanofi Pasteur, a Sanofi Company 300
Testing effectiveness (Phase 2)Study completedNCT01943305
What this trial is testing

The Role of Pre-existing Cross-reactive Antibodies in Determining the Efficacy of Vaccination in Humans

Who this might be right for
Yellow FeverEncephalitis, Japanese
Singapore General Hospital 84
Testing effectiveness (Phase 2)Study completedNCT00441259
What this trial is testing

Safety and Efficacy Study of ChimeriVax™-JE and JE Inactivated Mouse Brain Vaccine in Children of Descending Age

Who this might be right for
Japanese Encephalitis
Sanofi 96
Not applicableStudy completedNCT00596102
What this trial is testing

Longterm Immunogenicity of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 3,258
Large-scale testing (Phase 3)Study completedNCT03282370
What this trial is testing

Evaluate Safety and Immunogenicity of a Vero Cell-Derived JE Vaccine in 9-24 Months of Age Children in Vietnam

Who this might be right for
Japanese Encephalitis
National Institute of Hygiene and Epidemiology, Vietnam 655
Post-approval studies (Phase 4)Study completedNCT02514746
What this trial is testing

Long-term Immunogenicity After Receipt of JE Vaccine and Antibody Response and Safety to a Booster Dose

Who this might be right for
Encephalitis, Japanese
PATH 561
Large-scale testing (Phase 3)Study completedNCT01041573
What this trial is testing

Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population

Who this might be right for
Encephalitis
Valneva Austria GmbH 1,869
Not applicableLooking for participantsNCT07358910
What this trial is testing

Risk Assessment of Community Spread of Multiple Endemic Infectious Diseases in a One Health Perspective

Who this might be right for
DengueChikungunyaZika Virus Infection+55 more
Institut Pasteur du Cambodge 10,000
Post-approval studies (Phase 4)Study completedNCT01656200
What this trial is testing

A Prospective, Open Label Study of Human T Cell Responses to Live Attenuated Japanese Encephalitis Vaccine SA14-14-2

Who this might be right for
Japanese EncephalitisJapanese Encephalitis Vaccine
Indian Institute of Science 17
Large-scale testing (Phase 3)UnknownNCT04223037
What this trial is testing

Purified Inactivated Japanese Encephalitis Vaccine

Who this might be right for
Japanese Encephalitis Virus Disease
Chinese Academy of Medical Sciences 1,050
Post-approval studies (Phase 4)Active Not RecruitingNCT06825312
What this trial is testing

Immunogenicity, Safety, and Antibody Persistence of Different Immunization Strategies Against Japanese Encephalitis

Who this might be right for
Japanese Encephalitis Vaccine
Liaoning Chengda Biotechnology CO., LTD 600
Post-approval studies (Phase 4)Study completedNCT01815073
What this trial is testing

Immunogenicity and Safety of Live Attenuated Varicella Vaccine Combined With Live Attenuated JE Vaccine

Who this might be right for
Japanese EncephalitisChickenpox
Changchun Keygen Biological Products Co., Ltd. 497
Large-scale testing (Phase 3)Study completedNCT02545517
What this trial is testing

Clinical Trial to Evaluate Long-term Immunogenicity and Boostability of Purified Chick-Embryo Cell Rabies Vaccine in Adults Following Primary Series of Pre/Exposure Prophylaxis.

Who this might be right for
Virus DiseasesRabies
GlaxoSmithKline 459
Testing effectiveness (Phase 2)Study completedNCT03204227
What this trial is testing

Safety of Vero Cell - Derived Inactivated Japanese Encephalitis Vaccine (JECEVAX) in Children From 9-24 Months of Age

Who this might be right for
Japanese Encephalitis
National Institute of Hygiene and Epidemiology, Vietnam 220
Large-scale testing (Phase 3)Study completedNCT01900444
What this trial is testing

Study of a Booster Dose of IMOJEV® One Year After Primary Immunization in Healthy Children in South Korea

Who this might be right for
Japanese Encephalitis
Sanofi Pasteur, a Sanofi Company 119
Testing effectiveness (Phase 2)Study completedNCT00981175
What this trial is testing

ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults

Who this might be right for
EncephalitisJapanese Encephalitis
Sanofi 202
Testing effectiveness (Phase 2)Study completedNCT01856205
What this trial is testing

Safety and Efficacy Study of Intravenous Immunoglobulin to Treat Japanese Encephalitis

Who this might be right for
Japanese Encephalitis
University of Liverpool 22
Large-scale testing (Phase 3)Study completedNCT00605085
What this trial is testing

Safety and Tolerability of the Japanese Encephalitis Vaccine IC51

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH 2,675
Testing effectiveness (Phase 2)Study completedNCT00981630
What this trial is testing

Study of Live Attenuated ChimeriVax™-Japanese Encephalitis Vaccine

Who this might be right for
Japanese Encephalitis
Sanofi 128
Early research (Phase 1)WithdrawnNCT01559831
What this trial is testing

Immune Response in IXIARO Batch JEV09L37 Recipients Before and After Revaccination

Who this might be right for
Japanese Encephalitis
Valneva Austria GmbH
Load More Results